| Bioactivity | SARS-CoV-2-IN-21 (compound 10), a penicillin sulfone benzyl C6 derivative, is a potent SARS-CoV-2 main protease inhibitor, with an IC50 of 5.3 μM. SARS-CoV-2-IN-21 can be used for COVID-19 research[1]. |
| Target | IC50: 5.3 ± 3.3 μM (SARS-CoV-2 main protease) |
| Name | SARS-CoV-2-IN-21 |
| CAS | 89971-88-0 |
| Formula | C23H24N2O7S |
| Molar Mass | 472.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Malla TR, et al. Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine. J Med Chem. 2022 May 12:acs.jmedchem.1c02214. |
SARS-CoV-2-IN-21
CAS: 89971-88-0 F: C23H24N2O7S W: 472.51
SARS-CoV-2-IN-21 (compound 10), a penicillin sulfone benzyl C6 derivative, is a potent SARS-CoV-2 main protease inhibito
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.